CCR2 and atherosclerosis: Here, we leveraged whole-exome sequencing (WES) data from 454,775 participants of the population-based UK Biobank (UKB) study to explore whether rare damaging variants in the CCR2 gene are associated with cardiovascular disease risk, burden of atherosclerosis, and traditional vascular risk biomarkers.